Prediction: AMD Stock Will Jump 60% in 2026, Thanks to President Donald Trump

AMD is positioned to recover a material portion of the roughly $6.2 billion of 2024 revenue lost when U.S. export controls halted high-end chip sales to China in April, after the Trump administration announced it will permit advanced AI chips to be sold to Chinese customers (subject to a proposed 25% export fee). The company is on track for about $34 billion in 2025 revenue (up 31% year-over-year) and incurred an $800 million inventory charge in Q2; consensus EPS is $3.97 for 2025 and $6.46 for 2026 (a 62% increase). If China sales return to 2024 levels, the author projects 2026 revenue near $51 billion and, at a price-to-sales of 11x, a potential market-cap around $561 billion (implying ~60% upside), a scenario that could materially boost AMD shares and sector multiples.

Analysis

Market structure: The policy shift is a direct win for AMD (and NVDA/INTC) because Chinese demand for full-performance data-center GPUs was ~ $6.2B for AMD in 2024 — restoring even 50–75% of that in 2026 implies +$3–4.5B to revenue (7–11% upside to consensus 2026 revenue). Pricing power should improve for full GPUs vs nerfed SKUs, and limited TSMC/ASML capacity means supply constraints could keep gross margins elevated near-term. Volatility (IV) in AMD/NVDA options will likely stay elevated into the first half of 2026; risk-on could push equities higher and modestly widen credit spreads for less exposed semicap suppliers.

Risk assessment: Tail risks include a rapid policy reversal, Chinese retaliatory trade barriers, or denial of customer-level licenses that cut realized China sales by >50%; each would materially compress the “China recovery” case. Near-term (days–weeks) expect headline-driven price swings around license clarifications and earnings; medium-term (3–9 months) depends on shipment approvals and TSMC allocation; long-term (2026–2028) depends on Chinese substitution (domestic GPUs) and cadence of AMD architecture refresh. Hidden dependency: AMD’s upside is capacity-constrained — without confirmed wafer allocations incremental demand may be deferred.

Trade implications: Direct play — establish a measured long exposure to AMD to capture the China re-entry and margin lift; express via stock and defined-risk call spreads to control downside. Relative value — pair long AMD vs short INTC to monetize GPU-era share shift where Intel has weaker GPU traction. Sector — overweight equipment/supplier names (ASML, TSM) to play capacity tightening; de-risk duration exposure as risk-on raises yields.

Contrarian angles: Consensus underestimates execution risk (licenses + wafer access) and overestimates near-term revenue returning at 100%; conversely analysts haven’t yet priced any China upside so some upside may be underappreciated if shipments scale quickly. Historical parallels: 2019 Huawei constraints show buyers re-route, not instantly disappear — recovery is S-curve, not linear. Unintended consequence: faster China domestic investment could accelerate local competitors over 3–5 years, capping multi-year upside for incumbents.

Key Decisions for Investors

• Initiate a 2–3% portfolio long position in AMD (AMD) within the next 2–6 weeks, scaling in on any 10% pullbacks; set a tactical target of +40–60% by end-2026 if AMD reports China revenue recovery consistent with +$3–5B, and a hard stop-loss at -20% from entry to limit idiosyncratic policy risk.
• Buy a defined-risk AMD directional spread: Jan 2027 60/120 call spread sized to 1% portfolio risk (cost = net debit) to capture upside to a $51B revenue scenario while limiting premium outlay; exit if AMD fails to secure wafer allocation confirmations within 6 months or if spread value doubles.
• Implement a pair trade: long AMD 2% vs short INTC 2% (equal dollar) to express relative GPU-led share shift; unwind if AMD underperforms INTC by >15% over 90 days or if Intel announces a credible large-scale data-center GPU win.
• Overweight semicap suppliers for 6–18 months: add 1–2% positions in ASML (ASML) or TSM (TSMC ADR) to benefit from constrained lithography/wafer capacity; take profits if semiconductor equipment order books decelerate QoQ or if ASML/TSM guidance misses by >10%.